Cargando…

Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease

Stroke and vascular dementia are leading causes of morbidity and mortality. Neuroprotective therapies have been proposed but none have proven clinically tolerated and effective. While overstimulation of N-methyl-d-aspartate-type glutamate receptors (NMDARs) is thought to contribute to cerebrovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, Hiroto, Xia, Peng, Cui, Jiankun, Talantova, Maria, Bodhinathan, Karthik, Li, Wenjun, Holland, Emily A., Tong, Gary, Piña-Crespo, Juan, Zhang, Dongxian, Nakanishi, Nobuki, Larrick, James W., McKercher, Scott R., Nakamura, Tomohiro, Wang, Yuqiang, Lipton, Stuart A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609936/ https://www.ncbi.nlm.nih.gov/pubmed/26477507 http://dx.doi.org/10.1038/srep14781

Ejemplares similares

Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
por: Takahashi, Hiroto, et al.
Publicado: (2016)

MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model
por: Cho, Eun-Gyung, et al.
Publicado: (2011)

Molecular Pathway to Protection From Age-Dependent Photoreceptor Degeneration in Mef2 Deficiency
por: Nagar, Saumya, et al.
Publicado: (2017)

Memantine protects thalamocortical hyper‐glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc(−)
por: Okada, Motohiro, et al.
Publicado: (2019)

Transcriptional profiling of MEF2-regulated genes in human neural progenitor cells derived from embryonic stem cells
por: Chan, Shing Fai, et al.
Publicado: (2014)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models
por: Lipton, Stuart A, et al.
Publicado: (2016)

Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity
por: Lopes, João P, et al.
Publicado: (2013)

The effect of the NMDA channel blocker memantine on salicylate-induced tinnitus in rats
por: RALLI, M., et al.
Publicado: (2014)

Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice
por: Osanloo, Naser, et al.
Publicado: (2015)

NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism
por: Tu, Shichun, et al.
Publicado: (2017)

Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
por: Okamoto, Shu-ichi, et al.
Publicado: (2009)

The Estimated Impact of Drug Importation, Mandatory Mail Service, and Medicaid Fee Reduction on Community Pharmacies in Michigan
por: McKercher, Patrick L.
Publicado: (2006)

The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi
por: Santos Souza, Higo Fernando, et al.
Publicado: (2019)

Professional CUDA C programming
por: Cheng, John, et al.
Publicado: (2014)

Living on the edge
por: McKercher, Bob, et al.
Publicado: (2006)

The Over-Reaction to SARS and the Collapse of Asian Tourism
por: McKercher, Bob, et al.
Publicado: (2004)

Editorial: Special issue on CAUTHE 2021 conference
por: Scerri, Madalyn, et al.
Publicado: (2022)

Computational Modeling of Therapy with the NMDA Antagonist in Neurodegenerative Disease: Information Theory in the Mechanism of Action of Memantine
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult
por: Ferrer-Acosta, Yancy, et al.
Publicado: (2022)

Altered Actions of Memantine and NMDA-Induced Currents in a New Grid2-Deleted Mouse Line
por: Kumagai, Ayako, et al.
Publicado: (2014)

Virtual Therapy with the NMDA Antagonist Memantine in Hippocampal Models of Moderate to Severe Alzheimer’s Disease, In Silico Trials
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Do destinations have multiple lifecycles?
por: McKercher, Bob, et al.
Publicado: (2021)

Does the environment matter in the ‘new normal’?
por: Mkono, Mucha, et al.
Publicado: (2022)

Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond
por: Hasanagic, Senad, et al.
Publicado: (2020)

Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol
por: Sandström, Katharina O., et al.
Publicado: (2022)

Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review
por: Bessell, Erica, et al.
Publicado: (2015)

Memantine, an Antagonist of the NMDA Glutamate Receptor, Affects Cell Proliferation, Differentiation and the Intracellular Cycle and Induces Apoptosis in Trypanosoma cruzi
por: Damasceno, Flávia Silva, et al.
Publicado: (2014)

Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats
por: Ndlazi, Ziphozethu, et al.
Publicado: (2018)

NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models
por: Ghatak, Swagata, et al.
Publicado: (2021)

Nrf2 and HSF-1 Pathway Activation via Hydroquinone-Based Proelectrophilic Small Molecules Is Regulated by Electrochemical Oxidation Potential
por: Satoh, Takumi, et al.
Publicado: (2015)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
por: Pringle, A, et al.
Publicado: (2012)

Recovery of NMDA receptor currents from MK-801 blockade is accelerated by Mg(2+) and memantine under conditions of agonist exposure
por: McKay, Sean, et al.
Publicado: (2013)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

The NMDA antagonist memantine affects training induced motor cortex plasticity – a study using transcranial magnetic stimulation [ISRCTN65784760]
por: Schwenkreis, Peter, et al.
Publicado: (2005)

Dual Allosteric Effect in Glycine/NMDA Receptor Antagonism: A Comparative QSAR Approach
por: Sharma, Manish, et al.
Publicado: (2010)

Application of Real-World Data and the REWARD Framework to Detect Unknown Benefits of Memantine and Identify Potential Disease Targets for New NMDA Receptor Antagonists
por: Kern, David M., et al.
Publicado: (2021)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_46url8nltncejp3rpeqloun1kd